Prevalence of BRAF Mutation in Colorectal Cancer Among Lebanese Patients: A Descriptive Study
Journal of Clinical Medicine · 03.03.2026 · 15 (5) · 1913
DOI: 10.3390/jcm15051913 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.03.2026. Verfasst von Christelle Rahme und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, Central Michigan University, Mount Pleasant Campus, Mount Pleasant, MI 48859, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Although the BRAF gene mutation in colorectal cancer has a prognostic value and a therapeutic interest, very few studies address the prevalence of this mutation in the Middle East, and hardly any among the Lebanese population. Moreover, we studied the correlation between this mutation and other clinical and pathological variables.
Methods
In this descriptive, retrospective, single-center study, BRAF mutational status was reviewed in colorectal tumor samples collected from 2015 to 2021 of Lebanese patients with confirmed metastatic colorectal cancer. The genetic analysis was done in two different molecular laboratories. Clinical characteristics were selected from the computerized medical records of included patients. Statistical calculations were performed with SPSS (version 21.0) statistical software.
Results
The study included 190 patients. BRAF mutation was detected in 10 patients (5.3%). A positive correlation was observed between the presence of a BRAF mutation and the right-sidedness of the tumor (p = 0.001) as well as with the presence of microsatellite instability (p = 0.004). However, we could not establish a relationship between BRAF mutation and other characteristics such as age (p = 0.682), gender (p = 0.392), the degree of histologic differentiation (p = 0.594), and the presence of peritoneal metastases (p = 0.707).
Conclusions
The BRAF mutation was found in 5.3% of colorectal cancers in Lebanon. A positive correlation was suggested with the colon sidedness and the microsatellite instability. However, it was still insufficient to establish statistically significant associations between other variables and the BRAF mutation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, College of Medicine, Central Michigan University, Mount Pleasant Campus, Mount Pleasant, MI 48859, USA.
- Department of Hematology and Medical Oncology, Gustave Roussy Institute, 94800 Villejuif, France.
- Department of Pathology, Hôtel-Dieu de France, Saint Joseph University of Beirut, Beirut 166830, Lebanon.
- Department of Hematology and Medical Oncology, Hôtel-Dieu de France, Saint Joseph University of Beirut, Beirut 166830, Lebanon.
ORCID-Profile: Christelle Rahme, Trak Smayra Viviane
Zitieren
APA
Rahme, C., Josianne, B., Viviane, T. S., & Joseph, K. (2026). Prevalence of BRAF Mutation in Colorectal Cancer Among Lebanese Patients: A Descriptive Study. Journal of Clinical Medicine, 15(5), 1913. https://doi.org/10.3390/jcm15051913
Vancouver
Rahme C, Josianne B, Viviane TS, Joseph K. Prevalence of BRAF Mutation in Colorectal Cancer Among Lebanese Patients: A Descriptive Study. Journal of Clinical Medicine. 2026;15(5):1913. doi:10.3390/jcm15051913
BibTeX
@article{Rahme2026,
author = {Rahme, Christelle and Josianne, Bassil and Viviane, Trak Smayra and Joseph, Kattan},
title = {Prevalence of BRAF Mutation in Colorectal Cancer Among Lebanese Patients: A Descriptive Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {5},
pages = {1913},
doi = {10.3390/jcm15051913}
}
EUVIMED